Deal for 100 million doses with additional 100 million through 2023
_logo_256_384.jpg){kind=logo}
It supports sequencing-based COVID 19 surveillance in India
Drug formulations and biologics make impressive gains
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
It works as an adjunct to standard care based on robust clinical trials
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Price band in the range of Rs 933 to Rs 954
The group now has 320 approvals and has so far filed over 400 ANDAs
Subscribe To Our Newsletter & Stay Updated
